An Interleukin-1 Signature in Breast Cancer Treated With Interleukin-1 Receptor Blockade: Implications for Treating Cytokine Release Syndrome of Checkpoint Inhibitors
Cancer Research - United States
doi 10.1158/0008-5472.can-18-2225
Full Text
Open PDFAbstract
Available in full text
Date
September 14, 2018
Authors
Publisher
American Association for Cancer Research (AACR)